Page last updated: 2024-09-02

alpha-hydroxymetoprolol and Coronary Artery Disease

alpha-hydroxymetoprolol has been researched along with Coronary Artery Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bergmann, K; Eschenhagen, T; Feifel, N; Heide, R; Rau, T; Werner, U; Wuttke, H	1

Other Studies

1 other study(ies) available for alpha-hydroxymetoprolol and Coronary Artery Disease

Article	Year
Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment. Pharmacogenetics, 2002, Volume: 12, Issue:6 Topics: Adrenergic beta-Antagonists; Chromatography, High Pressure Liquid; Cohort Studies; Coronary Artery Disease; Cross-Sectional Studies; Cytochrome P-450 CYP2D6; DNA Primers; Drug Administration Schedule; Female; Gene Frequency; Genotype; Humans; Hypertension; Male; Metoprolol; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; White People	2002

Article

Year

Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment.

Pharmacogenetics, 2002, Volume: 12, Issue:6

Topics: Adrenergic beta-Antagonists; Chromatography, High Pressure Liquid; Cohort Studies; Coronary Artery Disease; Cross-Sectional Studies; Cytochrome P-450 CYP2D6; DNA Primers; Drug Administration Schedule; Female; Gene Frequency; Genotype; Humans; Hypertension; Male; Metoprolol; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; White People

2002